NUS Links:
Epstein-Barr virus (EBV) is associated with nasopharyngeal carcinoma (NPC) and provides a potential target for dendritic cell vaccine therapy. This phase 1 clinical study led by Prof Goh Boon Cher and A/Prof Herbert Schwarz indicates that a novel type of dendritic cells pulsed with EBV nuclear antigen LMP2 are safe and exhibits promising efficacy when administered following chemotherapy in patients with locally recurrent or metastatic NPC.
Link to website: https://bit.ly/30fD4Gg
Gastric cancer (GC) has significant global mortality with high heterogeneity. A study of 226 GC samples from 121 patients integrated …
The tumour microenvironment (TME) plays a pivotal role in cancer progression, metastasis, and therapeutic resistance. Comprised of diverse cells, extracellular …
Research led by N2CR member Dr. Cheok Chit Fang found that the tumour suppressor protein p53 protects DNA during replication …